Abstract
The nutritional status of 89 isolates of Burkholderia cepacia from 81 cystic fibrosis (CF) patients was evaluated. Forty of the isolates, from 38 patients, were not able to grow in a minimal medium containing glucose and mineral salts only and were thus auxotrophs. In contrast, all of 29 isolates from non-CF (clinical and environmental) sources were prototrophic. Addition of a pool of amino acids to the minimal medium was sufficient to promote growth of all tested CF auxotrophic isolates. Indeed, phenylalanine, tyrosine, cysteine, methionine, and histidine alone or in combination were required for growth by the majority of the nutritionally deficient B. cepacia isolates. Furthermore, extracts of sputum from CF patients, when added to minimal medium, promoted growth of 29 auxotrophic B. cepacia isolates regardless of their amino acid requirements. Finally, auxotrophic and prototrophic isolates from the same patient exhibited a conserved genotype, as determined by macrorestriction analysis of chromosomal DNA. These results suggest that the auxotrophic mutants are selected from the prototrophic population and maintained by the nutritionally rich environment of the CF airways.
Full Text
The Full Text of this article is available as a PDF (273.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barth A. L., Pitt T. L. Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis. J Clin Microbiol. 1995 Jan;33(1):37–40. doi: 10.1128/jcm.33.1.37-40.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Beckman W., Lessie T. G. Response of Pseudomonas cepacia to beta-Lactam antibiotics: utilization of penicillin G as the carbon source. J Bacteriol. 1979 Dec;140(3):1126–1128. doi: 10.1128/jb.140.3.1126-1128.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gilligan P. H., Gage P. A., Welch D. F., Muszynski M. J., Wait K. R. Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol. 1987 Jul;25(7):1258–1261. doi: 10.1128/jcm.25.7.1258-1261.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holmes B. The identification of Pseudomonas cepacia and its occurrence in clinical material. J Appl Bacteriol. 1986 Oct;61(4):299–314. doi: 10.1111/j.1365-2672.1986.tb04291.x. [DOI] [PubMed] [Google Scholar]
- KING E. O., WARD M. K., RANEY D. E. Two simple media for the demonstration of pyocyanin and fluorescin. J Lab Clin Med. 1954 Aug;44(2):301–307. [PubMed] [Google Scholar]
- Ohman D. E., Chakrabarty A. M. Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin. Infect Immun. 1982 Aug;37(2):662–669. doi: 10.1128/iai.37.2.662-669.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taylor R. F., Hodson M. E., Pitt T. L. Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa. Thorax. 1993 Oct;48(10):1002–1005. doi: 10.1136/thx.48.10.1002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taylor R. F., Hodson M. E., Pitt T. L. Auxotrophy of Pseudomonas aeruginosa in cystic fibrosis. FEMS Microbiol Lett. 1992 May 1;71(3):243–246. doi: 10.1016/0378-1097(92)90716-2. [DOI] [PubMed] [Google Scholar]